Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in the Treatment of Tobacco Use Disorder
NCT05452772Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Nov 2023
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in Tobacco Use Disorder (TUD), sponsored by Johns Hopkins University. Started Nov 2023; status: recruiting.
02
Drugs
psilocybin
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05452772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05452772.